|
Long-term follow-up of the randomized trial on open versus laparoscopic surgery for primary tumor resection in patients with non-curable stage IV colon cancer (JCOG1107). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Ono Pharmaceutical (Inst) |
|
|
Honoraria - Chugai Pharma; m3.com |
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); ONO PHARMACEUTICAL (Inst) |
|
|
Employment - ASAHI INTECC |
|
Stock and Other Ownership Interests - Jmees Inc. |
Honoraria - Applied Medical Japan; Bayer Yakuhin; Covidien; Fujifilm; Johnson & Johnson K.K. Medical Company; Kaken Pharmaceutical; MC Medical, Inc.; Nippon Covidien Ltd.; Olympus; Olympus; Taiho Pharmaceutical |
Consulting or Advisory Role - ASAHI INTECC |
Research Funding - Astellas Pharma; Fujifilm; Fujita Medical Instruments Co., Ltd.; Indivumed; Intelligent Surfaces, Inc.; Kawasumi Laboratories, Incorporated; Muranaka Medical Instruments Co., Ltd.; Nippon Covidien Ltd.; Olympus; Sumitomo Chemical; Sumitomo Chemical Co., Ltd.; Surg storage CO., Ltd. |
Patents, Royalties, Other Intellectual Property - BMG Inc.; EBM Co.; Fujita Medical Instruments CO., Ltd.; Muranaka Medical Instruments Co.; Olympus; Sumitomo Chemical; Takano Company Limited |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda |
Research Funding - Amgen - Local PI (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); Ono Pharmaceutical (Inst) |
|
|
Honoraria - Covidien; Ethicon |
|
|
No Relationships to Disclose |